Riduanul Islam Bhuiyan ( Riduan )

Experience

• 

  Nuvista Pharma

  Jun 2014 - Apr 2019

  Steroid Portfolio: CORTIFLO (Deflazacort), ORADEXON (Dexamethasone), Roxadex (Dexamethasone Sodium Phosphate), DECA DURABOLIN (Nandrolone Decanoate), DURABOLIN (Nandrolone Phenylpropionate), Adam 33 (Prednisolone)Hormone Portfolio: TESTANON Injection (Testosterone Decanoate + Isocaproate + Phenyl propionate + Propionate), Allygest (Allylestrenol)General Portfolio: Zifocap (Zinc, Carbonyl Iron & Folic Acid), Freemax (Aceclofenac), Torimon (Etoricoxib), Ketoshot (Ketorolac Tromethamine) & Gerdo (Esomeprazole)• Led the strategic positioning and marketing efforts for Gerdo, successfully establishing it as the company's top prescribing brand, achieving significant market share and revenue growth.• Developed and implemented targeted marketing strategies for Roxadex, positioning it as the brand of choice among Gynecologists and Obstetricians for promoting lung development in neonates during premature labor.• Successfully positioned Allygest as the preferred brand for the management of threatened abortion, gaining the trust of healthcare professionals and ensuring its adoption as the go-to solution in the market.• Revitalized the market presence of DECA DURABOLIN and DURABOLIN, positioning them as effective solutions for muscle development in patients with chronic diseases, leading to renewed interest from healthcare professionals and increased prescription rates.• Led the successful marketing and promotional activities for TESTANON Injection, resulting in its highest growth in terms of value and prescription, establishing it as a trusted choice among healthcare providers.• Conducted comprehensive market analysis and data analysis to identify key trends, customer preferences, and competitor insights, leveraging the findings to develop targeted marketing strategies and drive business growth. Show less Hormone Portfolio: Allygest (Allylestrenol)Hormone Portfolio (2nd Responsible): Marvelon (Desogestrel + Ethinyl Estradiol), Ovosta Gold (Lynestrenol + Ethinyl Estradiol)General Portfolio: Zifocap (Zinc, Carbonyl Iron & Folic Acid), Freemax (Aceclofenac), Torimon (Etoricoxib), Ketoshot(Ketorolac Tromethamine) & Gerdo (Esomeprazole)• Orchestrated the successful market entry and launch of Ketoshot (Ketorolac Tromethamine) in Bangladesh, implementing comprehensive marketing strategies and campaigns that resulted in rapid adoption and market penetration.• Spearheaded the revival of Nuvista Pharma's pain management portfolio, including Freemax (Aceclofenac), Torimon (Etoricoxib), and Ketoshot, by developing and executing innovative sales and prescription-based campaigns, leading to substantial revenue growth and increased market share.• Played a vital role in the development and launch of Elisa, Nuvista Pharma's first proprietary contraceptive pill & Setfree, Nuvista Pharma's emergency contraceptive pill contributing to the expansion of the company's product portfolio and capturing a significant share in the market.• Utilized central sales and marketing data analysis to provide actionable insights and recommendations to senior management, facilitating informed decision-making and driving business growth and profitability.• Implemented innovative marketing strategies for the general portfolio, encompassing Zifocap (Zinc, Carbonyl Iron & Folic Acid), Freemax (Aceclofenac), Torimon (Etoricoxib), and Gerdo (Esomeprazole), resulting in increased brand visibility, customer engagement, and revenue growth.• Conducted comprehensive market research and competitive analysis to identify emerging trends, customer preferences, and unmet needs, leveraging the findings to develop and execute targeted marketing strategies that drove product awareness, market share, and profitability. Show less • Developed and executed comprehensive training programs for the field forces, equipping them with product knowledge, selling skills, and market insights, resulting in enhanced sales performance and customer engagement.• Designed training aids and materials, ensuring the effective delivery of training content and maximizing trainee learning and retention.• Evaluated trainee performance and training program effectiveness, identifying areas for improvement and tailoring future initiatives to address specific needs.• Conducted Training of the Trainer (TOT) programs, equipping internal trainers to effectively deliver training sessions and maintain a high standard of training.• Provided scientific paper support to doctors and brand owners, delivering evidence-based information to enhance credibility among healthcare professionals.• Conducted clinical meetings to discuss product features, benefits, and usage guidelines, fostering relationships and increasing product adoption.• Coordinated with the marketing team for projects and campaigns, ensuring alignment between training initiatives and marketing strategies.• Collaborated with cross-functional teams to ensure training programs aligned with company goals and strategies.• Developed continuous learning programs to support ongoing skill development and knowledge enhancement among the field forces.• Successfully trained and developed a team of 150 Medical Information Officers (MIOs) within Nuvista Pharma's general team, enabling them to effectively communicate product information and achieve sales targets. Show less

  • Senior Product Executive

    Jan 2017 - Apr 2019

  • Product Executive

    Jul 2015 - Dec 2016

  • Product Executive ( Training)

    Jun 2014 - Jun 2015
• 

  Healthcare Pharmaceuticals Limited

  Apr 2019 - now

  HPL Portfolio: Mensil N (Micornised Norethisterone BP 5mg), Yulipris (Ulipristal Acetate INN 5mg), Athena (Ulipristal Acetate INN 30 mg) and Development of future HPL Organon Portfolio: Implanon NXT (Etonogestrel 68 mg) – World’s 1st and only single rod Implant• Drive the successful management and promotion of the HPL portfolio, including Mensil N (Micornised Norethisterone BP 5mg), Yulipris (Ulipristal Acetate INN 5mg), and Athena (Ulipristal Acetate INN 30 mg), by developing and implementing effective marketing strategies to increase brand awareness, market share, and revenue.• Lead the development of future HPL products, identifying market needs, conducting market research, and collaborating with cross-functional teams to drive product innovation and expansion, ensuring a robust product pipeline to meet evolving customer demands.• Oversee the launch and market introduction of Athena, HPL's first emergency pill, by developing comprehensive marketing plans, conducting training sessions for the sales team, and implementing promotional campaigns, resulting in successful market penetration and increased product adoption.• Manage the Organon portfolio, specifically Implanon NXT (Etonogestrel 68 mg), the world's first and only single rod implant, by implementing strategic marketing initiatives, providing scientific support to healthcare professionals, and collaborating with international stakeholders to ensure the product's success in the local market.• Supervise and mentor a team of Product Associates, providing guidance, support, and training to maximize their performance, foster professional growth, and ensure alignment with the company's goals and objectives. Show less Portfolio 01: Mensil N (Micornised Norethisterone BP 5mg) – 1st HPL HormonePortfolio 02: Andriol Testocaps (Testosterone Undecanoate 40 mg) – Product of MSD [Merck Sharp & Dohme] & Organon• Led the successful launch of Mensil N, the first HPL hormone in Bangladesh, achieving significant market penetration and securing the 4th position in the Norethisterone market within 1.5 years of launching, as per IQVIA Bangladesh data.• Managed the Andriol Testocaps product, a testosterone undecanoate formulation developed by MSD and Organon, ensuring its market presence and growth.• Developed and executed strategic marketing plans for the Hormone Portfolio at Healthcare Pharmaceuticals Limited, resulting in increased brand awareness and market share.• Conducted thorough market research and analysis to identify emerging trends, customer needs, and competitive landscape, contributing to informed decision-making and effective product positioning.• Collaborated cross-functionally with the R&D, Sales, and Regulatory teams to ensure seamless product development, registration, and launch processes, while complying with local regulations and industry standards.• Monitored key performance indicators (KPIs) and analyzed sales data to assess the effectiveness of marketing strategies, identify opportunities for improvement, and make data-driven recommendations to senior management.• Established and maintained strong relationships with key opinion leaders (KOLs), healthcare professionals, and industry stakeholders to foster brand advocacy and gain insights into market dynamics.• Trained and mentored a team of product associates, providing guidance on product knowledge, market dynamics, and sales strategies, resulting in enhanced team performance and individual growth.• Actively participated in industry conferences, trade shows, and professional networking events to stay updated on the latest trends, build industry connections, and explore potential business collaborations. Show less

  • Product Manager

    Jan 2023 - now

  • Senior Product Executive

    Apr 2019 - Dec 2022